Evidence map›Paper›PMID 33471952›Full record

ArticleAngewandte Chemie (International ed. in English)2021

Electrooxidative Rhodium-Catalyzed [5+2] Annulations via C-H/O-H Activations.

Yulei Wang, João C A Oliveira, Zhipeng Lin, Lutz Ackermann

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Distal Ruthenaelectro-Catalyzed meta-C-H Bromination with Aqueous HBr.Angewandte Chemie (International ed. in English) · 2022
    Article
  10. Article
  11. Electrooxidative Rhodium-Catalyzed [5+2] Annulations via C-H/O-H Activations.Angewandte Chemie (International ed. in English) · 2021
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yulei WangInstitut für Organische und Biomolekulare Chemie, and Wöhler Research Institute for Sustainable Chemistry, Georg-August-Universität Göttingen, Tammannstrasse 2, 37077, Göttingen, Germany.
João C A OliveiraInstitut für Organische und Biomolekulare Chemie, and Wöhler Research Institute for Sustainable Chemistry, Georg-August-Universität Göttingen, Tammannstrasse 2, 37077, Göttingen, Germany.
Zhipeng LinInstitut für Organische und Biomolekulare Chemie, and Wöhler Research Institute for Sustainable Chemistry, Georg-August-Universität Göttingen, Tammannstrasse 2, 37077, Göttingen, Germany.
Lutz AckermannInstitut für Organische und Biomolekulare Chemie, and Wöhler Research Institute for Sustainable Chemistry, Georg-August-Universität Göttingen, Tammannstrasse 2, 37077, Göttingen, Germany.ORCID http://orcid.org/0000-0001-7034-8772

Funding

Alexander von Humboldt-StiftungChina Sponsorship Council (CN)DFG
6 · The paper itself

Abstract

Electrooxidative annulations involving mild transition metal-catalyzed C-H activation have emerged as a transformative strategy for the rapid construction of five- and six-membered heterocycles. In contrast, we herein describe the first electrochemical metal-catalyzed [5+2] cycloadditions to assemble valuable seven-membered benzoxepine skeletons by C-H/O-H activation. The efficient alkyne annulation featured ample substrate scope, using electricity as the only oxidant. Mechanistic studies provided strong support for a rhodium(III/I) regime, involving a benzoxepine-coordinated rhodium(I) sandwich complex as the catalyst resting state, which was re-oxidized to rhodium(III) by anodic oxidation.

Indexed as

[5+2] cycloadditionbenzoxepineC−H activationelectrochemistryelectrooxidative annulation

Identifiers

PMID33471952
PMCPMC7986427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.